Jim Cramer says good cholesterol drug data is a breakout for Regeneron; he likes Regeneron over Sanofi.
Yep, the bets for the rest of 2014 are being placed.
Jim Cramer regards the Dollar Tree offer as the bird in the hand.
This initiation is a play on the secular theme of higher social and mobile Internet usage.
Catch up on Jim Cramer's thinking over the last week about the trajectory of Emerge Energy Services and what's propping up retail.
We added one name and dropped another this week amid light market volume.
We'll also trim Boeing and use some of the cash to buy RDS and Kinder Morgan.
Here's how you can get on the bandwagon.
There is a presumption that tomorrow will be worse than today.
We’re raising funds by trimming back Boeing and Xilinx.